{
  "input": {
    "mode": "execute_actions",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "items": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_mesalamine",
            "via": [],
            "to": "d_gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "明确机制路径以补充现有支持",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_infliximab",
            "via": [],
            "to": "d_gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "明确机制路径以补充现有支持",
            "assignee": "Proponent"
          }
        ]
      },
      {
        "hypothesis_id": "H3",
        "graph_actions": [
          {
            "type": "add_mechanism_link",
            "from": "drug_adalimumab",
            "via": [],
            "to": "d_gastrointestinal_epithelial_barrier_disorders",
            "success_criteria": "明确机制路径以补充现有支持",
            "assignee": "Proponent"
          }
        ]
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_gastrointestinal_epithelial_barrier_disorders",
          "type": "Disease",
          "label": "Gastrointestinal Epithelial Barrier Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Mesalamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Budesonide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Loperamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Probiotics",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_infliximab",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_adalimumab",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_budesonide",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_prednisone",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_ustekinumab",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_tocilizumab",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_methotrexate",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_azathioprine",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_cyclosporine",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_loperamide",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        },
        {
          "source": "drug_probiotics",
          "target": "d_gastrointestinal_epithelial_barrier_disorders",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "临床应用与疾病关联显著"
        }
      ],
      "round_index": 2
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "hypothesis_id": "H1",
    "executed_actions": [
      {
        "action_ref": 0,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_mesalamine",
              "target": "d_gastrointestinal_epithelial_barrier_disorders",
              "relation": "acts_on",
              "weight": 0.8,
              "agent": "Proponent",
              "rationale": "通过减少肠道炎症改善肠上皮屏障功能"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补充 Mesalamine 对于胃肠上皮屏障障碍的机制路径"
      },
      {
        "action_ref": 1,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_infliximab",
              "target": "d_gastrointestinal_epithelial_barrier_disorders",
              "relation": "acts_on",
              "weight": 0.85,
              "agent": "Proponent",
              "rationale": "通过抑制肿瘤坏死因子-alpha (TNF-α) 改善肠道屏障"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补充 Infliximab 对于胃肠上皮屏障障碍的机制路径"
      },
      {
        "action_ref": 2,
        "status": "done",
        "graph_updates": {
          "add_nodes": [],
          "add_edges": [
            {
              "source": "drug_adalimumab",
              "target": "d_gastrointestinal_epithelial_barrier_disorders",
              "relation": "acts_on",
              "weight": 0.83,
              "agent": "Proponent",
              "rationale": "通过抑制TNF-α改善肠道炎症及屏障功能"
            }
          ],
          "merge": [],
          "set_weights": []
        },
        "notes": "已补充 Adalimumab 对于胃肠上皮屏障障碍的机制路径"
      }
    ],
    "unexecuted_actions": [],
    "residual_gaps": []
  }
}